Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study
Author(s) -
Martina Rossi,
Mattia Buratto,
Stefania Bruni,
Carlo Filieri,
Federico Tagliati,
Giorgio Trasforini,
Roberta Rossi,
Maria Donatella Beccati,
Ettore C. degli Uberti,
Maria Chiara Zatelli
Publication year - 2012
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2011-3494
Subject(s) - thyroid nodules , medicine , malignancy , thyroid cancer , thyroid , papillary thyroid cancer , pathology , nodule (geology) , biopsy , v600e , fine needle aspiration , thyroid carcinoma , cancer , cytology , radiology , mutation , biology , paleontology , biochemistry , gene
Ultrasound (US)-guided fine-needle aspiration biopsy (FNAB) is the most reliable nonsurgical test for distinguishing benign from malignant thyroid nodules. However, there is no consensus on which nodules should undergo FNAB.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom